Your browser doesn't support javascript.
loading
Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1.
Zhu, Mengying; Wang, Hui; Ding, Yiluan; Yang, Yuanyuan; Xu, Zhuo; Shi, Li; Zhang, Naixia.
  • Zhu M; Analytical Research Center for Organic and Biological Molecules, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Wang H; University of Chinese Academy of Sciences, Beijing, China.
  • Ding Y; Analytical Research Center for Organic and Biological Molecules, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Yang Y; Analytical Research Center for Organic and Biological Molecules, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Xu Z; Analytical Research Center for Organic and Biological Molecules, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Shi L; Analytical Research Center for Organic and Biological Molecules, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Zhang N; University of Chinese Academy of Sciences, Beijing, China.
FASEB J ; 36(5): e22329, 2022 05.
Article en En | MEDLINE | ID: mdl-35476303
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ribonucleótido Reductasas / Tiazoles / Benzamidas / Ciclina D1 / Ubiquitina Tiolesterasa / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ribonucleótido Reductasas / Tiazoles / Benzamidas / Ciclina D1 / Ubiquitina Tiolesterasa / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article